全文获取类型
收费全文 | 5558篇 |
免费 | 564篇 |
国内免费 | 29篇 |
专业分类
耳鼻咽喉 | 32篇 |
儿科学 | 232篇 |
妇产科学 | 154篇 |
基础医学 | 762篇 |
口腔科学 | 81篇 |
临床医学 | 820篇 |
内科学 | 955篇 |
皮肤病学 | 74篇 |
神经病学 | 486篇 |
特种医学 | 231篇 |
外科学 | 871篇 |
综合类 | 215篇 |
现状与发展 | 20篇 |
一般理论 | 6篇 |
预防医学 | 546篇 |
眼科学 | 75篇 |
药学 | 281篇 |
中国医学 | 7篇 |
肿瘤学 | 303篇 |
出版年
2023年 | 83篇 |
2022年 | 52篇 |
2021年 | 175篇 |
2020年 | 105篇 |
2019年 | 136篇 |
2018年 | 200篇 |
2017年 | 149篇 |
2016年 | 159篇 |
2015年 | 164篇 |
2014年 | 196篇 |
2013年 | 257篇 |
2012年 | 311篇 |
2011年 | 406篇 |
2010年 | 197篇 |
2009年 | 198篇 |
2008年 | 250篇 |
2007年 | 251篇 |
2006年 | 250篇 |
2005年 | 253篇 |
2004年 | 209篇 |
2003年 | 188篇 |
2002年 | 178篇 |
2001年 | 119篇 |
2000年 | 114篇 |
1999年 | 120篇 |
1998年 | 76篇 |
1997年 | 60篇 |
1996年 | 81篇 |
1995年 | 59篇 |
1994年 | 43篇 |
1993年 | 47篇 |
1992年 | 60篇 |
1991年 | 77篇 |
1990年 | 65篇 |
1989年 | 62篇 |
1988年 | 74篇 |
1987年 | 46篇 |
1986年 | 61篇 |
1985年 | 52篇 |
1984年 | 51篇 |
1983年 | 48篇 |
1982年 | 43篇 |
1981年 | 26篇 |
1980年 | 29篇 |
1979年 | 34篇 |
1978年 | 33篇 |
1974年 | 28篇 |
1973年 | 34篇 |
1972年 | 21篇 |
1967年 | 23篇 |
排序方式: 共有6151条查询结果,搜索用时 490 毫秒
1.
2.
3.
4.
Fiene Marie Kuijper Uma V. Mahajan Seul Ku Daniel A.N. Barbosa Sheila M. Alessi Sherman C. Stein Kyle M. Kampman Brandon S. Bentzley Casey H. Halpern 《Neuromodulation》2022,25(2):253-262
ObjectivesCocaine is the second most frequently used illicit drug worldwide (after cannabis), and cocaine use disorder (CUD)-related deaths increased globally by 80% from 1990 to 2013. There is yet to be a regulatory-approved treatment. Emerging preclinical evidence indicates that deep brain stimulation (DBS) of the nucleus accumbens may be a therapeutic option. Prior to expanding the costly investigation of DBS for treatment of CUD, it is important to ensure societal cost-effectiveness.AimsWe conducted a threshold and cost-effectiveness analysis to determine the success rate at which DBS would be equivalent to contingency management (CM), recently identified as the most efficacious therapy for treatments of CUDs.Materials and MethodsQuality of life, efficacy, and safety parameters for CM were obtained from previous literature. Costs were calculated from a societal perspective. Our model predicted the utility benefit based on quality-adjusted life-years (QALYs) and incremental-cost-effectiveness ratio resulting from two treatments on a one-, two-, and five-year timeline.ResultsOn a one-year timeline, DBS would need to impart a success rate (ie, cocaine free) of 70% for it to yield the same utility benefit (0.492 QALYs per year) as CM. At no success rate would DBS be more cost-effective (incremental-cost-effectiveness ratio <$50,000) than CM during the first year. Nevertheless, as DBS costs are front loaded, DBS would need to achieve success rates of 74% and 51% for its cost-effectiveness to exceed that of CM over a two- and five-year period, respectively.ConclusionsWe find DBS would not be cost-effective in the short term (one year) but may be cost-effective in longer timelines. Since DBS holds promise to potentially be a cost-effective treatment for CUDs, future randomized controlled trials should be performed to assess its efficacy. 相似文献
5.
V Aerra M Kuduvalli AN Moloto AK Srinivasan AD Grayson BM Fabri AY Oo 《Journal of cardiothoracic surgery》2006,1(1):6-5
Background
Atrial fibrillation can occur in up to 40% of patients undergoing coronary surgery. 相似文献6.
Paul Wexberg MD BM Richard Pacher MD Suzanne Rdler MD Katharina Kiss MD Gilbert Beran MD Michael Grimm MD Gerald Maurer MD Dietmar Glogar MD FESC 《The Journal of heart and lung transplantation》2002,21(12):583-1263
BACKGROUND: Endothelin, a peptide with strong vasoconstrictive and mitogenic properties, has been found to increase after cardiac transplantation. We therefore assessed the association between its precursor peptide, big endothelin-1, and intimal hyperplasia and coronary flow reserve after heart transplantation. METHODS: Thirty-five patients without hemodynamically significant coronary artery disease after heart transplantation were investigated: Average peak flow velocity in the left anterior descending artery (LAD) was assessed by intracoronary Doppler at baseline as well as after injection of adenosine; coronary flow reserve was calculated as a ratio of both and was corrected for patient age and baseline average peak flow velocity. Lumen, intima + media and total vessel area were measured by intracoronary ultrasound. The plasma concentration of big endothelin-1 in venous blood was determined by radioimmunoassay. RESULTS: Patients with elevated big endothelin-1 levels (>2 fmol/ml) tended to have a decreased corrected coronary flow reserve (2.60 +/- 0.9 vs 3.21 +/- 1.0, p = 0.078). They also had a significantly larger intima + media area (5.82 +/- 2.9 vs 2.37 +/- 2.9 mm(2), p = 0.004) and total vessel area (18.36 +/- 5.8 vs 12.81 +/- 4.8 mm(2), p = 0.012) than those with normal plasma concentrations. CONCLUSIONS: Our study suggests an association between elevated big endothelin-1 plasma levels and the development of intimal hyperplasia and reduction of coronary flow reserve after cardiac transplantation. 相似文献
7.
8.
9.
10.